How to Buy Raaj Medisafe India Ltd Shares?
You can easily buy the stocks/shares of Raaj Medisafe India Ltd (RAAJMEDI) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Raaj Medisafe India Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of RAAJMEDI as on 15th May 2025 is ₹82.91What is the return on Raaj Medisafe India Ltd share?
The past returns of Raaj Medisafe India Ltd (RAAJMEDI) share are- Past 1 week: N/A
- Past 1 month: N/A
- Past 3 months: 27.27
- Past 6 months: 10.80
- Past 1 year: 4.07
- Past 3 years: 213.41
- Past 5 years: 876.97
What is the Dividend yield % on Raaj Medisafe India Ltd share?
The current dividend yield of Raaj Medisafe India Ltd (RAAJMEDI) is N/AWhat is the Market Cap of Raaj Medisafe India Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Raaj Medisafe India Ltd (RAAJMEDI) is ₹124.44Cr as of 15th May 2025What is the 52 Week High and Low of Raaj Medisafe India Ltd?
The 52-week high and low of Raaj Medisafe India Ltd (RAAJMEDI) is ₹122.60 and ₹63.56.What is the PE and PB ratio of Raaj Medisafe India Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Raaj Medisafe India Ltd are 20.33 and 11.49 respectively.Which sector does Raaj Medisafe India Ltd belong to?
Raaj Medisafe India Ltd (RAAJMEDI) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.What are the peers or stocks similar to Raaj Medisafe India Ltd?
The peers or stocks similar to Raaj Medisafe India Ltd are: and many others.Can't decide whether or not to buy Raaj Medisafe India Ltd?
Worry no more! Login to Tickertape and check out Raaj Medisafe India Ltd (RAAJMEDI) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Raaj Medisafe India Ltd?
The 52-week high and low of Raaj Medisafe India Ltd (RAAJMEDI) is ₹122.60 and ₹63.56.1. Test Stocks FAQ for Raaj Medisafe India Ltd Shares?
You can easily buy the stocks/shares of Raaj Medisafe India Ltd (RAAJMEDI) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Raaj Medisafe India Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of RAAJMEDI as on 15th May 2025 is ₹82.91
Raaj Medisafe India Ltd
RAAJMEDI Share Price
82.914.70% (-4.09)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
RAAJMEDI Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
BadThe stock is overpriced and in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
RAAJMEDI Performance & Key Metrics
RAAJMEDI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 20.33 | 11.49 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.01 | 6.54 | 0.84% |
RAAJMEDI Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
RAAJMEDI Company Profile
Raaj Medisafe is engaged in manufacturing of disposable hygiene products.
PE Ratio
54.67
54.67
1Y Return
13.99%
13.99%
Buy Reco %
25.00
25.00
POLYMED
PE Ratio
65.51
65.51
1Y Return
9.15%
9.15%
Buy Reco %
60.00
60.00
LAXMIDENTL
PE Ratio
75.55
75.55
1Y Return
11.08%
11.08%
Buy Reco %
100.00
100.00
TARSONS
PE Ratio
68.51
68.51
1Y Return
23.85%
23.85%
Buy Reco %
80.00
80.00
BOROSCI
PE Ratio
53.17
53.17
1Y Return
24.70%
24.70%
Buy Reco %
—
—
RAAJMEDI Sentiment Analysis
RAAJMEDI Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
RAAJMEDI Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
RAAJMEDI Stock Growth Drivers
RAAJMEDI Stock Growth Drivers
2Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
RAAJMEDI Stock Challenges
RAAJMEDI Stock Challenges
2Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
RAAJMEDI Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
RAAJMEDI Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
RAAJMEDI
RAAJMEDI
Income
Balance Sheet
Cash Flow
Annual Normal View
RAAJMEDI Income Statement
RAAJMEDI Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4.47 | 4.63 | 5.07 | 22.16 | 31.83 | 34.79 | 38.64 | 43.31 | 62.62 | 62.62 | ||||||||||
Raw Materials | 2.45 | 2.61 | 3.08 | 15.10 | 22.60 | 23.77 | 27.48 | 30.50 | 53.79 | 53.79 | ||||||||||
| Power & Fuel Cost | 0.53 | 0.51 | 0.57 | 1.21 | 1.30 | 1.31 | 1.53 | 1.72 | ||||||||||||
| Employee Cost | 0.53 | 0.69 | 0.83 | 2.15 | 2.44 | 2.89 | 2.70 | 3.25 | ||||||||||||
| Selling & Administrative Expenses | 0.26 | 0.28 | 0.38 | 0.90 | 1.19 | 1.44 | 1.32 | 1.69 | ||||||||||||
| Operating & Other expenses | 0.76 | 0.99 | 0.75 | 0.95 | 0.22 | 0.23 | -0.01 | -0.53 | ||||||||||||
EBITDA | -0.06 | -0.45 | -0.54 | 1.85 | 4.08 | 5.15 | 5.62 | 6.68 | 8.83 | 8.83 | ||||||||||
| Depreciation/Amortization | 0.27 | 0.31 | 0.31 | 0.68 | 0.71 | 0.72 | 0.75 | 0.84 | 1.45 | 1.45 | ||||||||||
| PBIT | -0.33 | -0.76 | -0.85 | 1.17 | 3.37 | 4.43 | 4.87 | 5.84 | 7.38 | 7.38 | ||||||||||
| Interest & Other Items | 0.51 | 0.66 | 0.75 | 1.16 | 0.74 | 0.71 | 1.11 | 1.57 | 2.13 | 2.13 | ||||||||||
| PBT | -0.84 | -1.42 | -1.60 | 0.01 | 2.63 | 3.72 | 3.76 | 4.27 | 5.25 | 5.25 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.31 | 0.32 | 0.71 | 0.44 | 0.96 | -0.87 | -0.87 | ||||||||||
| Net Income | -0.84 | -1.42 | -1.60 | -0.30 | 2.31 | 3.01 | 3.32 | 3.31 | 6.12 | 6.12 | ||||||||||
| EPS | -1.67 | -2.82 | -3.17 | -0.38 | 2.11 | 2.75 | 3.04 | 3.03 | 4.60 | 5.60 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
RAAJMEDI Company Updates
RAAJMEDI Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
RAAJMEDI Past Performance & Peer Comparison
RAAJMEDI Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation-basic on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Raaj Medisafe India Ltd | 20.33 | 11.49 | — |
| Inventurus Knowledge Solutions Ltd | 54.67 | 22.95 | — |
| Poly Medicure Ltd | 65.51 | 15.09 | 0.15% |
| Laxmi Dental Ltd | 75.55 | 53.87 | — |
RAAJMEDI Stock Price Comparison
Compare RAAJMEDI with any stock or ETFCompare RAAJMEDI with any stock or ETF
RAAJMEDI
RAAJMEDI Holdings
RAAJMEDI Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
RAAJMEDI Promoter Holdings Trend
RAAJMEDI Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
RAAJMEDI Institutional Holdings Trend
RAAJMEDI Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
RAAJMEDI Shareholding Pattern
RAAJMEDI Shareholding Pattern
RAAJMEDI Shareholding History
RAAJMEDI Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing RAAJMEDI stock
smallcases containing RAAJMEDI stock
Looks like this stock is not in any smallcase yet.
RAAJMEDI Events
RAAJMEDI Events
RAAJMEDI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
RAAJMEDI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
RAAJMEDI Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
RAAJMEDI has not given any dividends in last 5 years
RAAJMEDI Dividends
RAAJMEDI Dividends
Hmm, looks like data is unavailable here. Please come back after some timeRAAJMEDI Stock News & Opinions
RAAJMEDI Stock News & Opinions
Articles & Videos
Earnings
Raaj Medisafe India standalone net profit rises 397.14% in the March 2025 quarter
Net profit of Raaj Medisafe India rose 397.14% to Rs 3.48 crore in the quarter ended March 2025 as against Rs 0.70 crore during the previous quarter ended March 2024. Sales rose 114.79% to Rs 24.40 crore in the quarter ended March 2025 as against Rs 11.36 crore during the previous quarter ended March 2024. For the full year,net profit rose 84.08% to Rs 6.13 crore in the year ended March 2025 as against Rs 3.33 crore during the previous year ended March 2024. Sales rose 44.32% to Rs 62.42 crore in the year ended March 2025 as against Rs 43.25 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales24.4011.36 115 62.4243.25 44 OPM %12.7920.42 -13.8415.35 - PBDT2.551.89 35 6.715.13 31 PBT2.111.66 27 5.264.29 23 NP3.480.70 397 6.133.33 84 Powered by Capital Market - Live
4 weeks agoCapital Market - Live
Corporate
Raaj Medisafe India revises board meeting date
Raaj Medisafe India has revised the meeting of the Board of Directors which was scheduled to be held on 27 May 2025. The meeting will now be held on 29 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Raaj Medisafe India to convene board meeting
Raaj Medisafe India will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Raaj Medisafe India to conduct board meeting
Raaj Medisafe India will hold a meeting of the Board of Directors of the Company on 29 March 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Raaj Medisafe India standalone net profit rises 9.57% in the December 2024 quarter
Net profit of Raaj Medisafe India rose 9.57% to Rs 1.03 crore in the quarter ended December 2024 as against Rs 0.94 crore during the previous quarter ended December 2023. Sales rose 43.46% to Rs 14.59 crore in the quarter ended December 2024 as against Rs 10.17 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales14.5910.17 43 OPM %15.1514.95 - PBDT1.681.15 46 PBT1.280.94 36 NP1.030.94 10 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Raaj Medisafe India to hold board meeting
Raaj Medisafe India will hold a meeting of the Board of Directors of the Company on 11 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Raaj Medisafe India standalone net profit declines 38.68% in the September 2024 quarter
Net profit of Raaj Medisafe India declined 38.68% to Rs 0.65 crore in the quarter ended September 2024 as against Rs 1.06 crore during the previous quarter ended September 2023. Sales rose 11.79% to Rs 12.52 crore in the quarter ended September 2024 as against Rs 11.20 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales12.5211.20 12 OPM %12.6214.11 - PBDT1.101.26 -13 PBT0.721.06 -32 NP0.651.06 -39 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Raaj Medisafe India to announce Quarterly Result
Raaj Medisafe India will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Raaj Medisafe India AGM scheduled
Raaj Medisafe India announced that the Annual General Meeting (AGM) of the company will be held on 25 September 2024.Powered by Capital Market - Live
9 months agoCapital Market - Live
Earnings
Raaj Medisafe India standalone net profit rises 53.97% in the June 2024 quarter
Net profit of Raaj Medisafe India rose 53.97% to Rs 0.97 crore in the quarter ended June 2024 as against Rs 0.63 crore during the previous quarter ended June 2023. Sales rose 3.71% to Rs 10.91 crore in the quarter ended June 2024 as against Rs 10.52 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales10.9110.52 4 OPM %15.9511.50 - PBDT1.380.83 66 PBT1.150.63 83 NP0.970.63 54 Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 53.57%, vs industry avg of 17.66%
Over the last 5 years, market share increased from 0.42% to 0.79%